IM Cannabis (IMCC) EBIT Margin (2020 - 2026)
IM Cannabis (IMCC) recorded quarterly EBIT Margin of 19.31% in Q1 2026, up 60.68% quarter-over-quarter from 49.11% in Q4 2025, and down 2057.0% on a YoY basis from 0.99% in Q1 2025.
IM Cannabis (IMCC) EBIT Margin (2020 - 2026) Analysis & Trends
IM Cannabis' EBIT Margin history runs 7 years deep, the most recent figure standing at 19.31% for Q1 2026.
- In Q1 2026, EBIT Margin fell 2057.0% year-over-year to 19.31%; the TTM figure through Mar 2026 stood at 11.08% (up 3101.0% YoY), while the FY2025 annual figure was 21.17%, down 223.0% from the prior year.
- EBIT Margin was 19.31% for Q1 2026 at IM Cannabis, up from 49.11% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 2414.45% in Q4 2022 to a low of 904.55% in Q3 2022.
- Historically, EBIT Margin has averaged 58.98% across 5 years, with a median of 23.43% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin plunged 11584625 bps in 2022, then soared 88728 bps in 2023.
- A 5-year view of EBIT Margin shows it stood at 2414.45% in 2022, then slumped by 102 bps to 56.87% in 2023, then plunged by 174 bps to 155.92% in 2024, then jumped by 69 bps to 49.11% in 2025, then jumped by 61 bps to 19.31% in 2026.
- The last three EBIT Margin figures came in at 19.31% (Q1 2026), 49.11% (Q4 2025), and 27.9% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | IM Cannabis | 49,978.63 | -735,375.90 | 1.03 Mn | -19.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.31% |
| Dec 31, 2025 | -49.11% |
| Sep 30, 2025 | 27.90% |
| Jun 30, 2025 | -1.53% |
| Mar 31, 2025 | 1.26% |
| Dec 31, 2024 | -155.92% |
| Sep 30, 2024 | 7.79% |
| Jun 30, 2024 | -23.43% |
| Mar 31, 2024 | -46.67% |
| Dec 31, 2023 | -56.87% |
| Sep 30, 2023 | -17.27% |
| Jun 30, 2023 | -28.06% |
| Mar 31, 2023 | 28.87% |
| Dec 31, 2022 | 2,414.45% |
| Sep 30, 2022 | -904.55% |
| Jun 30, 2022 | -149.40% |
| Mar 31, 2022 | -25.44% |
| Dec 31, 2021 | 118,260.69% |
| Sep 30, 2021 | -70.35% |
| Jun 30, 2021 | -45.80% |